Determination of Galactosamine Containing Organic Impurities in Heparin by HPAE-PAD Using the CarboPac PA20 Column

Importance of the topic

The occurrence of life-threatening adverse events in 2008 linked to contaminated heparin highlighted the urgent need for sensitive analytical methods to detect organic impurities such as oversulfated chondroitin sulfate. Quantifying galactosamine released by acid hydrolysis provides a reliable marker for chondroitin sulfate adulteration in heparin, supporting product safety and pharmacopoeial compliance.

Objectives and Study Overview

This study evaluates a high-performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) method using the CarboPac PA20 column, as described in the revised USP heparin monograph. Key goals include:

• Determining galactosamine and glucosamine in hydrolyzed heparin samples
• Comparing electrolytically generated versus manually prepared KOH/NaOH eluents
• Testing method ruggedness across guard column configurations and multiple analytical columns

Methodology and Instrumentation

Samples of research-grade heparin (with and without dermatan sulfate spike) underwent acid hydrolysis (5 N HCl, 100 °C, 6 h) to release monosaccharides. Analysis was performed on a Dionex ICS-3000 RFIC-EG system, equipped with:

• AminoTrap pre-column and CarboPac PA20 guard/analytical columns
• EGC II KOH cartridge or manually prepared 14 mM and 100 mM hydroxide eluents
• Pulsed amperometric detection using a disposable gold electrode
• Gradient: 14 mM KOH (0–10 min), 100 mM KOH (10–20 min) at 0.5 mL/min, 30 °C

Main Results and Discussion

The method achieved baseline separation of galactosamine (GalN) and glucosamine (GlcN) with USP resolution >3.0, column efficiency >5000 theoretical plates, and peak asymmetry ~1.1. Limits of detection enabled quantification at 0.04% GalN (limit of detection) and reliable detection of 1% dermatan sulfate spike. Intraday and interday RSDs for spiked samples remained below 1%. Both eluent generation and manual preparation (using KOH or NaOH) produced equivalent performance. Simplified guard configurations maintained chromatographic integrity, and two separate CarboPac PA20 analytical columns yielded comparable results.

Benefits and Practical Applications

This HPAE-PAD approach provides a robust, reproducible, and sensitive assay for monitoring heparin purity in QC and QA laboratories. Automated eluent generation reduces preparation variability and streamlines compliance with USP monograph requirements. The method can be implemented on existing Dionex systems, facilitating rapid screening of raw materials and finished products for chondroitin sulfate contamination.

Future Trends and Potential Applications

Advancements may include:

• Integration of online digestion modules for automated sample preparation
• Miniaturized columns or capillary formats for faster separations
• Coupling with mass spectrometry for structural confirmation of impurities
• Application to other glycosaminoglycans and biologics
• Implementation within process analytical technology (PAT) frameworks for real-time monitoring

Conclusion

The described HPAE-PAD method on the CarboPac PA20 system robustly quantifies galactosamine impurities in heparin, meeting USP criteria for resolution, sensitivity, and precision. Both automated and manual eluent approaches, various guard configurations, and multiple columns demonstrate method ruggedness. Adoption of this protocol enhances safety assurance in heparin manufacturing and quality control.

References

1. WHO Alert No. 118, 2008. Contaminant Detected in Heparin Material.
2. FDA Public Health Update, 2008. Recall of Heparin Sodium Injection.
3. Guerrini M. et al., Nature Biotechnol., 2008, 26, 669–675.
4. USP Heparin Sodium Monograph Revision, Pharmacopeial Forum, 2009, 35(1), 1–10.
5. Dionex Application Note 235, LPN 2306, 2009.
6. Dionex Technical Note 21, LPN 034889-03, 1998.
7. Dionex Technical Note 71, LPN 1932-01, 2007.